Trial intelligence / Profile preview

Sorafenib Phase 2 trial in male patients (Japan, jRCT2080222462)

jRCT2080222462Phase 2Completed

Start
Apr 2014
Modality
Small Molecules
Countries
1
01

Overview

Phase 2 trial of sorafenib. Started Apr 2014; status: completed.

02

Drugs

sorafenib

Beyond the preview

Go deeper on jRCT2080222462.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on jRCT2080222462.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call